Trial Profile
An Exploratory Study to Assess the Effects of Fanapt on Social Cognitive Performance
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 15 Jul 2015
Price :
$35
*
At a glance
- Drugs Iloperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 24 Sep 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 02 Sep 2013 New trial record